Influence of age and gender before and after liver transplantation

Liver Transplantation

Volumn 19, Issue 2, 2013, Pages 122-134

  Burra, Patrizia ^a   Martin, Eleonora De ^a   Gitto, Stefano ^b   Villa, Erica ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AGE; AGE DISTRIBUTION; ALCOHOL LIVER DISEASE; ANTIVIRAL THERAPY; BODY MASS; CHRONIC LIVER DISEASE; ENZYME ACTIVITY; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; OSTEOPOROSIS; OUTCOME ASSESSMENT; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SEXUAL DYSFUNCTION; TREATMENT RESPONSE;

AGE FACTORS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MENOPAUSE; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 84873686368     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23574     Document Type: Review

References (135)

1. Floreani A,. Liver disorders in the elderly. Best Pract Res Clin Gastroenterol 2009; 23: 909-917.
2. Parolin MB, Rabinovitch I, Urbanetz AA, Scheidemantel C, Cat ML, Coelho JC,. Impact of successful liver transplantation on reproductive function and sexuality in women with advanced liver disease. Transplant Proc 2004; 36: 943-944. (Pubitemid 38766232)
3. Mass K, Quint EH, Punch MR, Merion RM,. Gynecological and reproductive function after liver transplantation. Transplantation 1996; 62: 476-479. (Pubitemid 26295822)
4. Jabiry-Zienjewicz Z, Kaminski P, Bobrowska K, Pietrzak B, Wielgos M, Zieniewicz K, Krawczyk M,. Menstrual cycle and sex hormone profile in perimenopausal women after liver transplantation. Transplant Proc 2006; 38: 2909-2912. (Pubitemid 44737914)
5. Poynard T, Bedossa P, Opolon P,. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-832. (Pubitemid 27129209)
6. Deuffic-Burban S, Poynard T, Valleron AJ,. Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model. J Viral Hepat 2002; 9: 114-122. (Pubitemid 36002474)
7. Yasuda M, Shimizu I, Shiba M, Ito S,. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 1999; 29: 719-727. (Pubitemid 29109585)
8. Shimizu I, Mizobuchi Y, Yasuda M, Shiba M, Ma YR, Horie T, et al. Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut 1999; 44: 127-136. (Pubitemid 29143293)
9. Codes L, Asselah T, Cazals-Hatem D, Tubach F, Vidaud D, Paraná R, et al. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut 2007; 56: 390-395. (Pubitemid 46579771)
10. Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, et al. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 2004; 40: 1426-1433. (Pubitemid 39657018)
11. Villa E, Vukotic R, Cammà C, Petta S, Di Leo A, Gitto S, et al. Reproductive status is associated with the severity of fibrosis in women with hepatitis C. PLoS One 2012; 7: e44624.
12. Pfeilschifter J, Köditz R, Pfohl M, Schatz H,. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90-119. (Pubitemid 34185307)
13. Harada H, Pavlick KP, Hines IN, Hoffman JM, Bharwani S, Gray L, et al. Selected contribution: effects of gender on reduced-size liver ischemia and reperfusion injury. J Appl Physiol 2001; 91: 2816-2822. (Pubitemid 33108049)
14. Eckhoff DE, Bilbao G, Frenette L, Thompson JA, Contreras JL,. 17-beta-estradiol protects the liver against warm ischemia/reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factor-alpha. Surgery 2002; 132: 302-309. (Pubitemid 35024777)
15. Shen SQ, Zhang Y, Xiong CL,. The protective effects of 17β-estradiol on hepatic ischemia-reperfusion injury in rat model, associated with regulation of heat-shock protein expression. J Surg Res 2007; 140: 67-76. (Pubitemid 46669544)
16. Vilatoba M, Eckstein C, Bilbao G, Frennete L, Eckhoff DE, Contreras JL,. 17β-estradiol differentially activates mitogen-activated protein-kinases and improves survival following reperfusion injury of reduced-size liver in mice. Transplant Proc 2005; 37: 399-403. (Pubitemid 40459800)
17. Jin B, Liu CZ, Hu SY, Wang TT, Wang L, Jiang XS, Frezza EE,. Influence of estrogen and androgen on the outcome of liver transplantation. Hepatogastroenterology 2008; 55: 207-211. (Pubitemid 351462192)
18. Polotsky HN, Polotsky AJ,. Metabolic implications of menopause. Semin Reprod Med 2010; 28: 426-434.
19. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR,. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474. (Pubitemid 29420675)
20. Farrell GC, Larter CZ,. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43 (suppl 1): S99-S112.
21. Angulo P,. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
22. Day CP,. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int 2006; 26: 1021-1028. (Pubitemid 44541742)
23. Watt KD, Charlton MR,. Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol 2010; 53: 199-206.
24. Park CW, Tsai NT, Wong LL,. Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more. Clin Transplant 2011; 25: E606-E611.
25. Burra P, Senzolo M, Adam R, Delvart V, Karam V, Germani G, Neuberger J,; for ELITA and ELTR Liver Transplant Centers. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010; 10: 138-148.
26. Berg CL, Steffick DE, Edwards EB, Heimbach JK, Magee JC, Washburn WK, Mazariegos GV,. Liver and intestine transplantation in the United States 1998-2007. Am J Transplant 2009; 9 (pt 2): 907-931.
27. Mehta MM, Moriarty KJ, Proctor D, Bird M, Darling W,. Alcohol misuse in older people: heavy consumption and protean presentations. J Epidemiol Community Health 2006; 60: 1048-1052. (Pubitemid 44861859)
28. Wilsnack RW, Wilsnack SC, Kristjanson AF, Vogeltanz-Holm ND, Gmel G,. Gender and alcohol consumption: patterns from the multinational GENACIS project. Addiction 2009; 104: 1487-1500.
29. Kerr-Corrêa F, Igami TZ, Hiroce V, Tucci AM,. Patterns of alcohol use between genders: a cross-cultural evaluation. J Affect Disord 2007; 102: 265-275. (Pubitemid 47049655)
30. Vogeltanz ND, Wilsnack SC, Vickers KS, Kristjanson AP,. Sociodemographic characteristics and drinking status as predictors of older women's health. J Gen Psychol 1999; 126: 135-147.
31. Dawson D,. Gender differences in the risk of alcohol dependence: United States, 1992. Addiction 1996; 91: 1831-1842. (Pubitemid 27032494)
32. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS,. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990; 322: 95-99. (Pubitemid 20023867)
33. Marshall AW, Kingstone D, Boss M, Morgan MY,. Ethanol elimination in males and females: relationship to menstrual cycle and body composition. Hepatology 1983; 3: 701-706. (Pubitemid 13007697)
34. Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res 2001; 25: 502-507. (Pubitemid 32323416)
35. Lim JK, Keeffe EB,. Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transpl 2004; 10 (suppl 2): S31-S38. (Pubitemid 39406099)
36. Adam R, McMaster P, O'Grady JG, Castaing D, Klempnauer JL, Jamieson N, et al.; for European Liver Transplant Association. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003; 9: 1231-1243. (Pubitemid 37536793)
37. Biselli M, Gramenzi A, Del Gaudio M, Ravaioli M, Vitale G, Gitto S, et al.; for Bologna Liver Transplantation Group. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study. J Clin Gastroenterol 2010; 44: 52-57.
38. European Liver Transplant Registry. www.eltr.org. Accessed November 2012.
39. Calvaruso V, Craxì A,. Fibrosis in chronic viral hepatitis. Best Pract Res Clin Gastroenterol 2011; 25: 219-230.
40. Thomas RM, Brems JJ, Guzman-Hartman G, Yong S, Cavaliere P, Van Thiel DH,. Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation. Liver Transpl 2003; 9: 905-915. (Pubitemid 37098838)
41. Pawlotsky JM,. Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus. Hepatology 2011; 53: 1742-1751.
42. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ,. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714. (Pubitemid 46780630)
43. Hanouneh IA, Feldstein AE, McCullough AJ, Miller C, Aucejo F, Yerian L, et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl 2008; 14: 1287-1293.
44. McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, et al.; for IDEAL Study Team. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med 2009; 361: 580-593.
45. Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, et al.; for Virahep-C Study Group. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 2006; 131: 470-477. (Pubitemid 44142464)
46. Villa E, Karampatou A, Cammà C, Di Leo A, Luongo M, Ferrari A, et al. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Gastroenterology 2011; 140: 818-829.
47. Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C,. Hormone replacement for osteoporosis in women with primary biliary cirrhosis. Cochrane Database Syst Rev 2011: CD009146.
48. Strassburg CP, Manns MP,. Autoimmune hepatitis in the elderly: what is the difference? J Hepatol 2006; 45: 480-482. (Pubitemid 44307390)
49. Cançado ELR, Porta G,. Autoimmune hepatitis in South America., Manns MP, Paumgartner G, Leuschner U, editors. In Immunology and the Liver. Falk symposium 114, Kluwer Academic Publishers and Falk Foundation, 2000, p. 82-92.
50. Strassburg CP, Manns MP,. Therapy of autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2011; 25: 673-687.
51. Schramm C, Kanzler S, zum Büschenfelde KH, Galle PR, Lohse AW,. Autoimmune hepatitis in the elderly. Am J Gastroenterol 2001; 96: 1587-1591. (Pubitemid 32455095)
52. Ilyas JA, O'Mahony CA, Vierling JM,. Liver transplantation in autoimmune liver diseases. Best Pract Res Clin Gastroenterol 2011; 25: 765-782.
53. Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE,. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 2001; 69: 321-326. (Pubitemid 34056794)
54. Guañabens N, Parés A,. Liver and bone. Arch Biochem Biophys 2010; 503: 84-94.
55. Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW, et al. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991; 14: 296-300.
56. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL,. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995; 95: 2581-2586.
57. Rosen H,. Primary biliary cirrhosis and bone disease. Hepatology 1995; 21: 253-255.
58. Forner A, Llovet JM, Bruix J,. Hepatocellular carcinoma. Lancet 2012; 379: 1245-1255.
59. El-Serag HB,. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002; 35 (suppl 2): S72-S78. (Pubitemid 35278644)
60. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J,. Cancer Incidence in Five Continents. Vol 7. Lyon, France: IARC Press; 1997. IARC scientific publication 143.
61. Muir CS, Waterhouse J, Mack T, Powell J, Whelan SL,. Cancer Incidence in Five Continents. Vol 5. Lyon, France: IARC Press; 1987. IARC scientific publication 88.
62. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr,. International trends and patterns of primary liver cancer. Int J Cancer 2001; 94: 290-296. (Pubitemid 32911426)
63. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M,. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317: 121-124. (Pubitemid 47056470)
64. Xu H, Wei Y, Zhang Y, Xu Y, Li F, Liu J, et al. Oestrogen attenuates tumour progression in hepatocellular carcinoma. J Pathol 2012; 228: 216-229.
65. Wang YC, Xu GL, Jia WD, Han SJ, Ren WH, Liu WB, et al. Protective effects of physiological doses of estrogen during hepatocarcinogenesis induced by diethylnitrosamine and N-nitrosomorpholine. Hepatogastroenterology 2011; 58: 2032-2035.
66. Madersbacher S, Ludvik G, Stulnig T, Grünberger T, Maier U,. The impact of liver transplantation on endocrine status in men. Clin Endocrinol (Oxf) 1996; 44: 461-466. (Pubitemid 26141691)
67. Gavaler JS,. Alcohol effects on hormone levels in normal postmenopausal women and in postmenopausal women with alcohol-induced cirrhosis. Recent Dev Alcohol 1995; 12: 199-208.
68. Burra P, Germani G, Masier A, De Martin E, Gambato M, Salonia A, et al. Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure? Transplantation 2010; 89: 1425-1429.
69. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al.; for Italian Study Group for Quality of Life in Cirrhosis. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120: 170-178. (Pubitemid 32061881)
70. Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther 2009; 30: 469-476.
71. Klassen AC, Klassen DK, Brookmeyer R, Frank RG, Marconi K,. Factors influencing waiting time and successful receipt of cadaveric liver transplant in the United States. 1990 to 1992. Med Care 1998; 36: 281-294. (Pubitemid 128456373)
72. Myers RP, Shaheen AA, Aspinall AI, Quinn RR, Burak KW,. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol 2011; 54: 462-470.
73. Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ,. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008; 300: 2371-2378.
74. Marino IR, Doyle HR, Aldrighetti L, Doria C, McMichael J, Gayowski T, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22: 1754-1762.
75. Lai JC, Feng S, Roberts JP, Terrault NA,. Gender differences in liver donor quality are predictive of graft loss. Am J Transplant 2011; 11: 296-302.
76. Duffy JP, Kao K, Ko CY, Farmer DG, McDiarmid SV, Hong JC, et al. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg 2010; 252: 652-661.
77. Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, et al. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl 2007; 13: 733-740. (Pubitemid 46796545)
78. Lai JC, Verna EC, Brown RS Jr, O'Leary JG, Trotter JF, Forman LM, et al.; for Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology 2011; 54: 418-424.
79. Karim Z, Intaraprasong P, Scudamore CH, Erb SR, Soos JG, Cheung E, et al. Predictors of relapse to significant alcohol drinking after liver transplantation. Can J Gastroenterol 2010; 24: 245-250.
80. Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nüssler NC,. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007; 13: 197-205. (Pubitemid 46351644)
81. Baccaro LF, Boin IF, Pedro AO, Costa-Paiva L, Leal AL, Ramos CD, Pinto-Neto AM,. Decrease in bone mass in women after liver transplantation: associated factors. Transplant Proc 2011; 43: 1351-1356.
82. Ho JK, Ko HH, Schaeffer DF, Erb SR, Wong C, Buczkowski AK, et al. Sexual health after orthotopic liver transplantation. Liver Transpl 2006; 12: 1478-1484. (Pubitemid 44594277)
83. Coffin CS, Shaheen AA, Burak KW, Myers RP,. Pregnancy outcomes among liver transplant recipients in the United States: a nationwide case-control analysis. Liver Transpl 2010; 16: 56-63.
84. Deshpande NA, James NT, Kucirka LM, Boyarsky BJ, Garonzik-Wang JM, Cameron AM, et al. Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis. Liver Transpl 2012; 18: 621-629.
85. Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM,. Sex-based disparities in liver transplant rates in the United States. Am J Transplant 2011; 11: 1435-1443.
86. Fink MA, Berry SR, Gow PJ, Angus PW, Wang BZ, Muralidharan V, et al. Risk factors for liver transplantation waiting list mortality. J Gastroenterol Hepatol 2007; 22: 119-124. (Pubitemid 44953426)
87. Rustgi VK, Marino G, Halpern MT, Johnson LB, Umana WO, Tolleris C,. Role of gender and race mismatch and graft failure in patients undergoing liver transplantation. Liver Transpl 2002; 8: 514-518. (Pubitemid 34619082)
88. Wittnich C, Belanger MP, Askin N, Boscarino C, Wallen WJ,. Lower liver transplant success in females: gender differences in metabolic response to global ischemia. Transplant Proc 2004; 36: 1485-1488. (Pubitemid 38903010)
89. Soric S, Belanger MP, Askin N, Wittnich C,. Impact of female sex hormones on liver tissue lactic acidosis during ischemia. Transplantation 2007; 84: 763-770. (Pubitemid 47480662)
90. Aduen JF, Sujay B, Dickson RC, Heckman MG, Hewitt WR, Stapelfeldt WH, et al. Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc 2009; 84: 973-978.
91. Waki K,. UNOS liver registry: ten year survivals. Clin Transpl 2006: 29-39.
92. Levy MF, Somasundar PS, Jennings LW, Jung GJ, Molmenti EP, Fasola CG, et al. The elderly liver transplant recipient: a call for caution. Ann Surg 2001; 233: 107-113. (Pubitemid 32042780)
93. Emre S, Mor E, Schwartz ME, Katz E, Acarli K, Fukuzawa K, Miller CM,. Liver transplantation in patients beyond age 60. Transplant Proc 1993; 25 (pt 2): 1075-1076. (Pubitemid 23078902)
94. Collins BH, Pirsch JD, Becker YT, Hanaway MJ, Van der Werf WJ, D'Alessandro AM, et al. Long-term results of liver transplantation in older patients 60 years of age and older. Transplantation 2000; 70: 780-783.
95. Garcia CE, Garcia RF, Mayer AD, Neuberger J,. Liver transplantation in patients over sixty years of age. Transplantation 2001; 72: 679-684. (Pubitemid 32802753)
96. Weigle WO,. Effects of aging on the immune system. Hosp Pract (Off Ed) 1989; 24: 112-119.
97. Cross TJ, Antoniades CG, Muiesan P, Al-Chalabi T, Aluvihare V, Agarwal K, et al. Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl 2007; 13: 1382-1388. (Pubitemid 47629570)
98. Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001; 7: 363-373. (Pubitemid 32331542)
99. Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J,. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009; 9: 782-793.
100. Seo S, Maganti K, Khehra M, Ramsamooj R, Tsodikov A, Bowlus C, et al. De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl 2007; 13: 844-847. (Pubitemid 46947849)
101. Lin JW, Caffrey JL, Chang MH, Lin YS,. Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality-cohort analysis from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2010; 95: 4258-4267.
102. Pfitzmann R, Nüssler NC, Hippler-Benscheidt M, Neuhaus R, Neuhaus P,. Long-term results after liver transplantation. Transpl Int 2008; 21: 234-246. (Pubitemid 351197348)
103. Laryea M, Watt KD, Molinari M, Walsh MJ, McAlister VC, Marotta PJ, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 2007; 13: 1109-1114. (Pubitemid 47305029)
104. Moon JI, Barbeito R, Faradji RN, Gaynor JJ, Tzakis AG,. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up. Transplantation 2006; 82: 1625-1628. (Pubitemid 46035640)
105. Reuben A,. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transpl 2001; 7 (suppl 1): S13-S21.
106. Kim C,. Does menopause increase diabetes risk? Strategies for diabetes prevention in midlife women. Womens Health (Lond Engl) 2012; 8: 155-167.
107. Neal DA, Tom BD, Luan J, Wareham NJ, Gimson AE, Delriviere LD, et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation 2004; 77: 93-99. (Pubitemid 38116878)
108. Gisbert C, Prieto M, Berenguer M, Bretõ M, Carrasco D, de Juan M, et al. Hyperlipidemia in liver transplant recipients: prevalence and risk factors. Liver Transpl Surg 1997; 3: 416-422.
109. Trapani L, Pallottini V,. Age-related hypercholesterolemia and HMG-CoA reductase dysregulation: sex does matter (a gender perspective). Curr Gerontol Geriatr Res 2010: 420139.
110. Wakatsuki A, Sagara Y,. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol 1995; 85: 523-528.
111. Ikenoue N, Wakatsuki A, Okatani Y,. Small low-density lipoprotein particles in women with natural or surgically induced menopause. Obstet Gynecol 1999; 93: 566-570. (Pubitemid 29147077)
112. de Aloysio D, Gambacciani M, Meschia M, Pansini F, Bacchi Modena A, Bolis PF, et al. The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group. Atherosclerosis 1999; 147: 147-153. (Pubitemid 29486784)
113. Yoshida T, Takahashi K, Yamatani H, Takata K, Kurachi H,. Impact of surgical menopause on lipid and bone metabolism. Climacteric 2011; 14: 445-452.
114. Stevenson JC, Crook D, Godsland IF,. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98: 83-90. (Pubitemid 23010426)
115. Richards J, Gunson B, Johnson J, Neuberger J,. Weight gain and obesity after liver transplantation. Transpl Int 2005; 18: 461-466. (Pubitemid 41726882)
116. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48. (Pubitemid 47016245)
117. De Gottardi A, Spahr L, Gelez P, Morard I, Mentha G, Guillaud O, et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med 2007; 167: 1183-1188. (Pubitemid 46919822)
118. Mackie J, Groves K, Hoyle A, Garcia C, Garcia R, Gunson B, Neuberger J,. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transpl 2001; 7: 418-427. (Pubitemid 32496144)
119. Burra P,. Hepatitis C. Semin Liver Dis 2009; 29: 53-65.
120. De Martin E, Senzolo M, Ponziani FR, Viganò R, Iemmolo RM, Donato MF, et al. Impact of antiviral therapy on fibrosis progression due to HCV recurrence after liver transplantation: results from the AISF RECOLT-C study group [abstract]. Liver Transpl 2011; 17 (suppl 1): S97.
121. Ebeling PR,. Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab 2009; 94: 1483-1490.
122. Kulak CA, Borba VZ, Kulak J Jr, Custõdio MR,. Osteoporosis after transplantation. Curr Osteoporos Rep 2012; 10: 48-55.
123. Defranco DJ, Lian JB, Glowacki J,. Differential effects of glucocorticoid on recruitment and activity of osteoclasts induced by normal and osteocalcin-deficient bone implanted in rats. Endocrinology 1992; 131: 114-121.
124. Canalis E, Delany AM,. Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci 2002; 966: 73-81. (Pubitemid 34729163)
125. Epstein S,. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 1996; 11: 1-7. (Pubitemid 26026737)
126. Goffin E, Devogelaer JP, Depresseux G, Squifflet JP, Pirson Y,. Osteoporosis after organ transplantation. Lancet 2001; 357: 1623.
127. Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martínez de Osaba MJ, et al. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int 2001; 68: 83-86. (Pubitemid 32289863)
128. Melton LJ III,. How many women have osteoporosis now? J Bone Miner Res 1995; 10: 175-177.
129. Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH,. Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 2004; 10: 648-653. (Pubitemid 38628225)
130. Burra P,. Sexual dysfunction after liver transplantation. Liver Transpl 2009; 15 (suppl 2): S50-S56.
131. Park ES, Villanueva CA, Viers BR, Siref AB, Feloney MP,. Assessment of sexual dysfunction and sexually related personal distress in patients who have undergone orthotopic liver transplantation for end-stage liver disease. J Sex Med 2011; 8: 2292-2298.
132. Armenti VT, Constantinescu S, Moritz MJ, Davison JM,. Pregnancy after transplantation. Transplant Rev (Orlando) 2008; 22: 223-240.
133. Murthy SK, Heathcote EJ, Nguyen GC,. Impact of cirrhosis and liver transplant on maternal health during labor and delivery. Clin Gastroenterol Hepatol 2009; 7: 1367-1372.
134. Kim HW, Seok HJ, Kim TH, Han DJ, Yang WS, Park SK,. The experience of pregnancy after renal transplantation: pregnancies even within postoperative 1 year may be tolerable. Transplantation 2008; 85: 1412-1419.
135. Surti B, Tan J, Saab S,. Pregnancy and liver transplantation. Liver Int 2008; 28: 1200-1206.